Evidence map›Paper›PMID 37335903›Full record

ArticleTranslational behavioral medicine2023

Consumers pay attention to ingredients on the front of a label: an eye tracking study.

Mark Lowry, Anne K Julian, Calvin Tribby, Frank Perna

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational behavioral medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mark LowryDivision of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.ORCID 0000-0003-4625-0163
Anne K JulianDivision of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Calvin TribbyDivision of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Frank PernaDivision of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Funding

NCI NIH HHS
6 · The paper itself

Abstract

Sunscreen is an important part of skin cancer prevention. The Food and Drug Administration (FDA) proposed numerous changes to sunscreen labeling including adding active ingredients to the front of a label. The purpose of the study was to identify and describe differences in attention between current label formatting and the proposed label formatting. Forty-seven participants were interviewed. Participants were presented with mock sunscreen labels that resembled current labeling or labeling based on the proposed FDA rule. While reading the labels, eye movements were recorded. Participants spent 12.3 s longer looking at the front of the proposed rule-compliant label than they did on the front of the current label. They spent the longest time reading the directions (13-14 seconds) compared with other areas. Placing active ingredients on the front of a label in relatively large font makes it more likely consumers will look at the information.

Indexed as

Choice BehaviorFood LabelingConsumer BehaviorEye-Tracking TechnologyHumansSunscreening AgentsSunscreening AgentsActive ingredientsAttentionEye trackingProposed FDA ruleSunscreen labels

Identifiers

PMID37335903
PMCPMC10538469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.